Nautilus Biotechnology (NAUT) Set to Announce Earnings on Tuesday

Nautilus Biotechnology (NASDAQ:NAUT) is set to issue its quarterly earnings data before the market opens on Tuesday, October 29th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Nautilus Biotechnology (NASDAQ:NAUT) last issued its quarterly earnings data on Tuesday, July 30th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.02. During the same quarter in the previous year, the business earned ($0.13) earnings per share. On average, analysts expect Nautilus Biotechnology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nautilus Biotechnology Trading Down 1.1 %

Shares of NAUT opened at $2.69 on Monday. The firm has a market cap of $336.96 million, a P/E ratio of -4.89 and a beta of 1.22. Nautilus Biotechnology has a 12-month low of $2.19 and a 12-month high of $3.45. The company’s 50-day moving average price is $2.73 and its 200 day moving average price is $2.61.

Insider Buying and Selling at Nautilus Biotechnology

In other Nautilus Biotechnology news, VP Mary E. Godwin sold 47,031 shares of Nautilus Biotechnology stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $2.87, for a total value of $134,978.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 40.50% of the stock is currently owned by corporate insiders.

Nautilus Biotechnology Company Profile

Nautilus Biotechnology, Inc, a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.